HEADER HYDROLASE/HYDROLASE INHIBITOR 18-JUN-13 2M9P TITLE NMR STRUCTURE OF AN INHIBITOR BOUND DENGUE NS3 PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE PROTEASE SUBUNIT NS2B, SERINE PROTEASE NS3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1391-1440 AND 1476-1648; COMPND 5 SYNONYM: FLAVIVIRIN PROTEASE NS2B REGULATORY SUBUNIT, NON-STRUCTURAL COMPND 6 PROTEIN 2B; COMPND 7 EC: 3.4.21.91, 3.6.1.15, 3.6.4.13; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: SERINE PROTEASE INHIBITOR; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DENGUE VIRUS 2; SOURCE 3 ORGANISM_TAXID: 413041; SOURCE 4 STRAIN: THAILAND/0168/1979; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PET11A; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS NS2B COFACTOR, COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.GIBBS,B.TOUNGE,R.STEELE REVDAT 3 15-NOV-23 2M9P 1 LINK ATOM REVDAT 2 14-JUN-23 2M9P 1 REMARK LINK REVDAT 1 09-JUL-14 2M9P 0 JRNL AUTH A.GIBBS,B.TOUNGE,R.STEELE JRNL TITL NMR STRUCTURE OF AN INHIBITOR BOUND DENGUE NS3 PROTEASE JRNL TITL 2 PROVIDES NEW INSIGHTS INTO THE NS2B NS3 LIGAND INTERACTIONS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2M9P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000103385. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.8 MM [U-13C; U-15N; U-2H] REMARK 210 PROTEIN, 0.8 MM [U-5% 13C; U-100% REMARK 210 15N] PROTEIN, 0.8 MM [U-13C; U- REMARK 210 15N; U-2H];[1H-13C]-I(DELTA1)LVM REMARK 210 PROTEIN, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HN(CA)CO; 3D REMARK 210 HNCO; 3D CBCA(CO)NH; 3D HNCACB; REMARK 210 3D 1H-15N NOESY; 3D 1H-13C NOESY; REMARK 210 3D HCCH-TOCSY; 3D CCH-TOCSY; 3D REMARK 210 CCH-NOESY; 3D CNH-NOESY; 3D NCH- REMARK 210 NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR, AUTOSTRUCTURE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE SERINE PROTEASE INHIBITOR BEZ-NLE-LYS-ARG-M9P IS PEPTIDE-LIKE, REMARK 400 A MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: SERINE PROTEASE INHIBITOR BEZ-NLE-LYS-ARG-M9P REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 4 11.37 -170.95 REMARK 500 1 ASP A 5 82.33 -158.25 REMARK 500 1 LYS A 15 109.74 -167.96 REMARK 500 1 GLU A 17 60.46 -157.88 REMARK 500 1 GLN A 19 4.27 -150.28 REMARK 500 1 ALA A 20 70.91 11.84 REMARK 500 1 SER A 23 -162.46 -174.84 REMARK 500 1 SER A 25 98.17 64.02 REMARK 500 1 ASP A 36 -55.55 76.05 REMARK 500 1 LYS A 42 -79.63 53.16 REMARK 500 1 LEU A 50 132.61 68.54 REMARK 500 1 GLU A 60 -69.53 -90.48 REMARK 500 1 PHE A 61 -86.23 48.30 REMARK 500 1 ALA A 62 -52.36 -177.31 REMARK 500 1 LEU A 65 129.96 69.29 REMARK 500 1 ASP A 67 69.58 179.64 REMARK 500 1 PRO A 72 104.14 -42.78 REMARK 500 1 PRO A 73 39.03 -82.05 REMARK 500 1 ALA A 77 11.58 -142.08 REMARK 500 1 GLU A 104 -84.28 66.13 REMARK 500 1 THR A 114 -83.61 -148.29 REMARK 500 1 ASP A 136 55.37 74.46 REMARK 500 1 LEU A 146 -25.46 169.24 REMARK 500 1 GLU A 147 83.78 67.49 REMARK 500 1 ALA A 160 99.10 -63.53 REMARK 500 1 PRO A 174 171.92 -59.37 REMARK 500 1 ALA A 186 -169.95 -162.63 REMARK 500 1 VAL A 207 160.55 90.77 REMARK 500 1 VAL A 208 13.80 -174.34 REMARK 500 1 ARG A 218 -74.63 69.89 REMARK 500 1 SER A 219 26.21 -164.42 REMARK 500 1 LYS A 231 -141.02 -91.88 REMARK 500 1 GLU A 234 -72.52 174.07 REMARK 500 1 PRO A 237 -177.48 -60.38 REMARK 500 1 ILE A 239 -45.08 -153.07 REMARK 500 1 LYS B 253 -76.08 68.51 REMARK 500 1 ARG B 254 -30.27 73.50 REMARK 500 2 ALA A 12 -158.45 178.37 REMARK 500 2 SER A 23 -35.71 -148.68 REMARK 500 2 SER A 25 -68.72 -103.90 REMARK 500 2 PRO A 27 -74.27 -70.85 REMARK 500 2 LYS A 42 -74.78 57.88 REMARK 500 2 GLU A 44 130.78 -174.13 REMARK 500 2 GLU A 45 27.51 -166.52 REMARK 500 2 GLU A 47 139.72 -173.59 REMARK 500 2 GLN A 48 79.91 -158.06 REMARK 500 2 ALA A 62 -65.43 70.12 REMARK 500 2 PRO A 73 84.05 -45.70 REMARK 500 2 VAL A 74 -36.32 -137.64 REMARK 500 2 LYS A 76 -42.49 -157.34 REMARK 500 REMARK 500 THIS ENTRY HAS 319 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 207 VAL A 208 1 -144.39 REMARK 500 TRP A 16 GLU A 17 6 148.94 REMARK 500 LYS A 89 GLY A 90 6 149.84 REMARK 500 GLY A 93 TYR A 94 6 146.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 3 ALA A 186 -11.08 REMARK 500 5 ALA A 186 -10.53 REMARK 500 9 ALA A 186 -11.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2M9Q RELATED DB: PDB REMARK 900 RELATED ID: 19305 RELATED DB: BMRB DBREF 2M9P A 1 240 PDB 2M9P 2M9P 1 240 DBREF 2M9P B 251 255 PDB 2M9P 2M9P 251 255 SEQRES 1 A 240 GLY SER ALA ALA ASP LEU GLU LEU GLU ARG ALA ALA ASP SEQRES 2 A 240 VAL LYS TRP GLU ASP GLN ALA GLU ILE SER GLY SER SER SEQRES 3 A 240 PRO ILE LEU SER ILE THR ILE SER GLU ASP GLY SER MET SEQRES 4 A 240 SER ILE LYS ASN GLU GLU GLU GLU GLN THR LEU GLY GLY SEQRES 5 A 240 GLY GLY SER GLY GLY GLY GLY GLU PHE ALA GLY VAL LEU SEQRES 6 A 240 TRP ASP VAL PRO SER PRO PRO PRO VAL GLY LYS ALA GLU SEQRES 7 A 240 LEU GLU ASP GLY ALA TYR ARG ILE LYS GLN LYS GLY ILE SEQRES 8 A 240 LEU GLY TYR SER GLN ILE GLY ALA GLY VAL TYR LYS GLU SEQRES 9 A 240 GLY THR PHE HIS THR MET TRP HIS VAL THR ARG GLY ALA SEQRES 10 A 240 VAL LEU MET HIS LYS GLY LYS ARG ILE GLU PRO SER TRP SEQRES 11 A 240 ALA ASP VAL LYS LYS ASP LEU ILE SER TYR GLY GLY GLY SEQRES 12 A 240 TRP LYS LEU GLU GLY GLU TRP LYS GLU GLY GLU GLU VAL SEQRES 13 A 240 GLN VAL LEU ALA LEU GLU PRO GLY LYS ASN PRO ARG ALA SEQRES 14 A 240 VAL GLN THR LYS PRO GLY LEU PHE LYS THR ASN ALA GLY SEQRES 15 A 240 THR ILE GLY ALA VAL SER LEU ASP PHE SER PRO GLY THR SEQRES 16 A 240 SER GLY SER PRO ILE ILE ASP LYS LYS GLY LYS VAL VAL SEQRES 17 A 240 GLY LEU TYR GLY ASN GLY VAL VAL THR ARG SER GLY ALA SEQRES 18 A 240 TYR VAL SER ALA ILE ALA GLN THR GLU LYS SER ILE GLU SEQRES 19 A 240 ASP ASN PRO GLU ILE GLU SEQRES 1 B 5 BEZ NLE LYS ARG M9P MODRES 2M9P NLE B 252 LEU NORLEUCINE HET BEZ B 251 13 HET NLE B 252 19 HET M9P B 255 29 HETNAM BEZ BENZOIC ACID HETNAM NLE NORLEUCINE HETNAM M9P AMINO{[(4S,5S)-4-AMINO-6,6,6-TRIFLUORO-5- HETNAM 2 M9P HYDROXYHEXYL]AMINO}METHANIMINIUM FORMUL 2 BEZ C7 H6 O2 FORMUL 2 NLE C6 H13 N O2 FORMUL 2 M9P C7 H16 F3 N4 O 1+ SHEET 1 A 8 LYS A 124 ILE A 126 0 SHEET 2 A 8 LEU A 119 HIS A 121 -1 N LEU A 119 O ILE A 126 SHEET 3 A 8 LEU A 6 ALA A 12 1 N LEU A 6 O MET A 120 SHEET 4 A 8 GLY A 82 GLY A 90 -1 O ARG A 85 N GLU A 9 SHEET 5 A 8 GLY A 93 LYS A 103 -1 O SER A 95 N GLN A 88 SHEET 6 A 8 THR A 106 MET A 110 -1 O HIS A 108 N VAL A 101 SHEET 7 A 8 LEU A 137 TYR A 140 -1 O ILE A 138 N THR A 109 SHEET 8 A 8 TRP A 130 ASP A 132 -1 N ASP A 132 O LEU A 137 SHEET 1 B 9 GLU A 21 GLY A 24 0 SHEET 2 B 9 PRO A 167 LYS A 173 1 O ALA A 169 N GLU A 21 SHEET 3 B 9 VAL A 156 LEU A 161 -1 N VAL A 156 O THR A 172 SHEET 4 B 9 SER A 198 ASP A 202 -1 O ILE A 201 N GLN A 157 SHEET 5 B 9 GLY A 209 THR A 217 -1 O GLY A 209 N ILE A 200 SHEET 6 B 9 ALA A 221 ALA A 227 -1 O VAL A 223 N VAL A 215 SHEET 7 B 9 THR A 183 SER A 188 -1 N VAL A 187 O SER A 224 SHEET 8 B 9 GLY A 175 LYS A 178 -1 N GLY A 175 O ALA A 186 SHEET 9 B 9 LEU A 29 SER A 30 1 N LEU A 29 O LYS A 178 SHEET 1 C 2 THR A 32 SER A 34 0 SHEET 2 C 2 SER A 38 SER A 40 -1 O SER A 38 N SER A 34 LINK OG SER A 196 C M9P B 255 1555 1555 1.45 LINK C BEZ B 251 N NLE B 252 1555 1555 1.34 LINK C NLE B 252 N LYS B 253 1555 1555 1.36 LINK C ARG B 254 N M9P B 255 1555 1555 1.36 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1